Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SARS-CoV-2-IN-41 (compound 2) is a potent inhibitor of SARS-CoV-2 3CL protease, exhibiting an IC50 of 0.022 µM and demonstrating antiviral efficacy [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | SARS-CoV-2-IN-41 (compound 2) is a potent inhibitor of SARS-CoV-2 3CL protease, exhibiting an IC50 of 0.022 µM and demonstrating antiviral efficacy [1]. |
In vivo | SARS-CoV-2-IN-41, administered intraperitoneally at doses of 50 and 200 mg/kg, exhibits antiviral activity against SARS-CoV-2 infection in mice [1]. |
Molecular Weight | 549.63 |
Formula | C22H30F3N5O4S2 |
CAS No. | 2920904-06-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SARS-CoV-2-IN-41 2920904-06-7 Microbiology/Virology SARS-CoV inhibitor inhibit